Jiangsu gdk Biotechnology Co., Ltd.

Jiangsu gdk Biotechnology Co., Ltd.

688670.SS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.61B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Jiangsu gdk Biotechnology Co., Ltd.Jiangsu gdk Biotechnology Co., Ltd.-9.1--17%-0.1
$-10.56

Current Fair Value

180.9% downside

Overvalued by 180.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.61 Billion
Enterprise Value$1.68 Billion
Earnings per Share$-1.41
Beta0.25
Outstanding Shares123,200,000

Return

Return on Equity-17.47%ROE
Return on Assets-14.01%
Return on Invested Capital-16.24%

Valuation & Multiples

P/E Ratio-9.07P/E Ratio
PEG49.91PEG
Price to Sales-Price to Sales
Price to Book Ratio1.63Price to Book Ratio
Enterprise Value to Revenue42.59
Enterprise Value to EBIT-9.66
Enterprise Value to Net Income-10
Total Debt to Enterprise0.07
Debt to Equity0.12Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 2, 2026
EPS
-$0.31
Reported
Revenue
$9,536
Reported

Next Earnings Call

Expected Date
April 22, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Jiangsu gdk Biotechnology Co., Ltd.

357 employees
CEO: Jianhui Zhang

Jiangsu gdk Biotechnology Co., Ltd. operates as a biotechnology firm specializing in the comprehensive research, development, manufacturing, and commercialization of human vaccines, alongside providing related services. Its current portf...